Stryker Corporation SYK
NYSE · Healthcare · Medical - Devices
$310.00
Close on Fri, 20 Nov 2026 · market value $118B
What the price is betting on
In line with its recordAt $310, the price assumes revenue grows about 8.3% a year for five years, from $26.3B to about $36.9B by FY2030. That is about the same as what analysts expect for the next two years and about the same as the company's own last three years.
Revenue growth a year. The price figure comes from a reverse DCF at a 8.3% discount rate.
Track it and Parra checks each report against the path, and tells you when revenue falls behind it.
Own more than SYK? Check up to 5 of your stocks at once, free, no account.
Both sides
Three stories, three values
Bear
$249
Base
$292
Bull
$343
Today $310
- Bear $249. Cash flow grows 4% a year for the next 5 years, slower than expected, then slows to long-run growth.
- Base $292. Cash flow grows 7% a year for the next 5 years, as analysts expect, then slows to long-run growth.
- Bull $343. Cash flow grows 10% a year for the next 5 years, faster than expected, then slows to long-run growth.
Stories set by rules from the company’s record.
Checkpoints
The revenue the price needs
- YearNeedsAnalysts expect
- FY2026$26.8B$26.8B, on the path
- FY2027$29.1B$28.7B, on the path
- FY2028$31.5B$30.9B, on the path
- FY2029$34.1B$33B, below the path
- FY2030$36.9B$35.3B, below the path
Each year's revenue at 8.3% growth from $26.3B in the 12 months to September 2026.
At a glance
Healthcare · Medical - Devices · listed on NYSE
- Revenue, FY2025
- $25.1B
- Growth, 3 years a year
- 9.5%
- Cash margin
- 17%
- Net debt
- $12.3B
- Shares, 3-year change
- 0%
- Dividend yield
- 1.1%
What other healthcare prices are betting on
Figures from company filings and end-of-day market data, as of the close on Fri, 20 Nov 2026; updated every trading day. This page shows what today's price assumes, not whether to buy or sell. Not investment advice.